Lea's Shield®: Colposcopic and microbiological testing during 8 weeks of use

Christine K. Mauck, Mitchell D Creinin, Wes Rountree, Marianne M. Callahan, Sharon L. Hillier

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Objectives: The aims of this study were to assess the effects of Lea's Shield® plus nonoxynol-9 spermicide on signs and symptoms of female genital irritation and cervical and vaginal microflora during 8 weeks of use with intercourse and to analyze problems associated with the use of the device. Methods: In this open-label, single-arm study, participants were evaluated by pelvic examination, colposcopy and vaginal and cervical cultures. Results: About 13% of women (4/30) reported symptoms of irritation, and minor product-related colposcopic findings were seen in about one third (11/30). Although average colony counts for enterococcus, Escherichia coli and anaerobic gram-negative rods increased during product use, no clinical diagnoses of infection were made. Most users reported at least one problem using Lea's Shield. Conclusion: Lea's Shield, when used for 8 weeks during intercourse, is associated with evidence of genital irritation in a minority of users and with changes in vaginal microflora that do not appear to correlate with clinical infections.

Original languageEnglish (US)
Pages (from-to)53-59
Number of pages7
Issue number1
StatePublished - Jul 2005
Externally publishedYes


  • Barrier
  • Colposcopy
  • Contraception
  • Device
  • Diaphragm
  • Lea's Shield®
  • Vagina

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology


Dive into the research topics of 'Lea's Shield®: Colposcopic and microbiological testing during 8 weeks of use'. Together they form a unique fingerprint.

Cite this